Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Angew Chem Int Ed Engl ; : e202413759, 2024 Sep 05.
Article in English | MEDLINE | ID: mdl-39235300

ABSTRACT

A straightforward, mild, and transition metal-free three-component coupling reaction involving arynes, phosphites, and silyl fluorides was developed through Si-F bond activation.  Although the Si-F bond is one of the strongest bonds, Si-C bond formation via Si-F bond cleavage with the assistance of bidentate silicon and phosphonium Lewis acids has been successfully achieved.  This unprecedented strategy provides a facile approach for synthesizing ortho-silyl-substituted aryl phosphonates.  Notably, this method allows the use of not only dialkylarylsilyl fluorides and diarylalkylsilyl fluorides but also triarylsilyl fluorides as coupling partners, which is uncommon in the field of arylsilane synthesis.  Furthermore, a variety of ortho-silyl-substituted aryl phosphonates were produced in moderate to good yields with broad functional group tolerance.  Additionally, the versatility of ortho-silyl-substituted aryl phosphonates was demonstrated by the elaboration of the products into a range of silicon-containing compounds.

2.
Biosens Bioelectron ; 82: 40-8, 2016 Aug 15.
Article in English | MEDLINE | ID: mdl-27040940

ABSTRACT

Transglutaminase 2 (TG2) is an enzyme that plays a critical role in a wide variety of cellular processes through its multifunctional activities. TG2 kinase has emerged as an important regulator of apoptosis, as well as of chromatin structure and function. However, systematic investigation of TG2 kinase substrates is limited due to a lack of a suitable TG2 kinase activity assays. Thus, we developed a novel on-chip TG2 kinase activity assay for quantitative determination of TG2 kinase activity and for screening TG2 kinase substrate proteins in a high-throughput manner. Quantitative TG2 kinase activity was determined by selective detection of substrate protein phosphorylation on the surface of well-type amine arrays. The limit of detection (LOD) of this assay was 4.34µg/ml. We successfully applied this new activity assay to the kinetic analysis of 27 TG2-related proteins for TG2 kinase activity in a high-throughput manner and determined Michaelis-Menten constants (Km) of these proteins. We used the Km values and cellular locations of the TG2-related proteins to construct a substrate affinity map for TG2 kinase. Therefore, this on-chip TG2 kinase activity assay has a strong potential for the systematic investigation of substrate proteins and will be helpful for studying new physiological functions.


Subject(s)
Biosensing Techniques/instrumentation , GTP-Binding Proteins/metabolism , Protein Array Analysis/instrumentation , Protein Kinases/metabolism , Transglutaminases/metabolism , Apoptosis , Enzyme Assays/instrumentation , Equipment Design , Humans , Kinetics , Phosphorylation , Protein Glutamine gamma Glutamyltransferase 2 , Substrate Specificity
3.
Biosens Bioelectron ; 79: 930-7, 2016 May 15.
Article in English | MEDLINE | ID: mdl-26802575

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) regulates nicotinamide adenine dinucleotide phosphate (NADPH) levels and is related to the pathogenesis of various diseases, including G6PD deficiency, type 2 diabetes, aldosterone-induced endothelial dysfunction, and cancer. Therefore, a highly sensitive array-based assay for determining quantitative G6PD activity is required. Here, we developed an on-chip G6PD activity assay using liquid droplet fluorescence arrays. Quantitative G6PD activity was determined by calculating reduced resorufin concentrations in liquid droplets. The limit of detection (LOD) of this assay was 0.162 mU/ml (2.89 pM), which is much more sensitive than previous assays. We used our activity assay to determine kinetic parameters, including Michaelis-Menten constants (Km) and maximum rates of enzymatic reaction (Vmax) for NADP(+) and G6P, and half-maximal inhibitory concentrations (IC50). We successfully applied this new assay to determine G6PD activity in human plasma from normal healthy individuals (n=30) and patients with inflammation (n=30). The inflammatory group showed much higher G6PD activities than did the normal group (p<0.001), with a high area under the curve value of 0.939. Therefore, this new activity assay has the potential to be used for diagnosis of G6PD-associated diseases and utilizing kinetic studies.


Subject(s)
Enzyme Assays/instrumentation , Glucosephosphate Dehydrogenase/blood , Lab-On-A-Chip Devices , Adult , Aged , Aged, 80 and over , Biosensing Techniques/instrumentation , Equipment Design , Female , Glucose-6-Phosphate/metabolism , Glucosephosphate Dehydrogenase/metabolism , Humans , Kinetics , Male , Middle Aged , NADP/metabolism , Oxazines/chemistry , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL